Financial Highlights
Net Profit for the quarter at
Mr.
About
Contact:
Tel: +91 022- 66953681
Email: ajay.desai@alembic.co.in
(C) 2023 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
102.8 INR | -1.28% | +2.00% | +13.49% |
May. 30 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
May. 13 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
Financial Highlights
Net Profit for the quarter at
Mr.
About
Contact:
Tel: +91 022- 66953681
Email: ajay.desai@alembic.co.in
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+13.49% | 316M | |
+22.85% | 26.29B | |
+20.95% | 26.03B | |
-15.93% | 25.09B | |
-3.39% | 24.65B | |
+27.64% | 20.8B | |
+3.63% | 20.26B | |
-2.15% | 18.65B | |
+52.13% | 18.54B | |
+1.01% | 16.35B |